公开(公告)号：US20020193787A1

公开(公告)日：2002-12-19

申请号：US10219798

申请日：2002-08-15

Applicant: Curon Medical, Inc.

Inventor： Jay Qin ,  Robin Bek ,  John Gaiser ,  David S. Utley

IPC: A61B018/04

CPC classification number: A61B18/1477 ,  A61B18/00 ,  A61B18/1492 ,  A61B90/90 ,  A61B2017/00017 ,  A61B2017/00084 ,  A61B2017/00199 ,  A61B2017/00269 ,  A61B2017/00482 ,  A61B2018/0022 ,  A61B2018/00267 ,  A61B2018/00494 ,  A61B2018/00791 ,  A61B2018/00988 ,  A61B2090/0814

Abstract: A device for treating a tissue region is supplied with a separate usage key card. The usage key card comprises a storage medium, which is formatted to contain an identification code unique to the usage key card. The usage key card is adapted to be read by a remote reader, to download the identification code for processing by a controller for the device. Processing of the identification code by the controller either enables or disables operation of the device according to prescribed criteria. A viewable image is generated on a display screen that changes in response to processing of the identification code.

公开(公告)号：US20020162555A1

公开(公告)日：2002-11-07

申请号：US10017685

申请日：2001-12-14

Applicant: Curon Medical, Inc.

Inventor： Scott West ,  David S. Utley ,  John W. Gaiser

IPC: A61M016/00 ,  A62B018/08

CPC classification number: A61B18/1485 ,  A61B1/00154 ,  A61M16/0493 ,  A61M25/02 ,  A61M29/02 ,  A61M2025/024 ,  Y10S128/06 ,  Y10S128/26

Abstract: Systems and methods are provided for positioning and stabilizing an external instrument during insertion of the instrument through the oral cavity (e.g., insertion of a catheter through the oral cavity and into the esophagus or cardia for treatment of gastroesophageal reflux disease (GERD)). The systems and methods provide a gripping tool for association with a bite block, capable of selectively moving between an open position in which the instrument may be inserted or removed, and a closed position in which the external instrument is held in a fixed position.

Abstract translation: 提供了系统和方法，用于在将器械插入口腔（例如，将导管穿过口腔插入食管或贲门以治疗胃食管反流病（GERD））期间定位和稳定外部器械。 这些系统和方法提供了一种用于与咬合块相关联的夹持工具，其能够选择性地在可以插入或移除该器械的打开位置之间移动，以及将外部器械保持在固定位置的关闭位置。

公开(公告)号：US20020151871A1

公开(公告)日：2002-10-17

申请号：US10017906

申请日：2001-12-14

Applicant: Curon Medical, Inc.

Inventor： John W. Gaiser ,  Scott West ,  David S. Utley ,  David Huynh

IPC: A61M025/01 ,  A61M025/09 ,  A61M031/00 ,  A61M029/00

CPC classification number: A61B18/1492 ,  A61B1/00154 ,  A61M16/0493 ,  A61M25/02 ,  A61M2025/024

Abstract: Systems and methods for treating a tissue region employ an expandable structure projecting beyond the distal end of a catheter tube. A distal tail projects beyond the far end of the basket assembly. The distal tail includes a guidewire lumen that accommodates passage of a guidewire without threading the guidewire through the catheter tube.

Abstract translation: 用于治疗组织区域的系统和方法使用突出超过导管管的远端的可扩张结构。 远端的尾巴超出了篮子组件的远端。 远端尾部包括导丝管腔，该导丝腔容纳导丝的通道，而不将导丝穿过导管。

公开(公告)号：US20020115992A1

公开(公告)日：2002-08-22

申请号：US09994379

申请日：2001-11-26

Applicant: Curon Medical, Inc.

Inventor： David S. Utley ,  John W. Gaiser ,  Rachel Croft

IPC: A61B018/14

CPC classification number: A61B18/1477 ,  A61B1/31 ,  A61B18/12 ,  A61B18/1206 ,  A61B18/1485 ,  A61B18/1492 ,  A61B2018/00011 ,  A61B2018/00029 ,  A61B2018/00077 ,  A61B2018/00148 ,  A61B2018/00214 ,  A61B2018/00232 ,  A61B2018/00261 ,  A61B2018/00267 ,  A61B2018/00273 ,  A61B2018/00285 ,  A61B2018/00291 ,  A61B2018/00482 ,  A61B2018/00553 ,  A61B2018/00654 ,  A61B2018/0066 ,  A61B2018/00702 ,  A61B2018/00755 ,  A61B2018/00791 ,  A61B2018/00797 ,  A61B2018/00815 ,  A61B2018/00875 ,  A61B2018/00898 ,  A61B2018/0091 ,  A61B2018/00916 ,  A61B2018/046 ,  A61B2018/1425 ,  A61B2018/1475 ,  A61B2090/3782 ,  A61B2218/002 ,  A61B2218/007

Abstract: Systems and methods apply a selected treatment agent or agents into contact with tissue at or in the region of a dysfunctional sphincter (in the case of GERD, fecal incontinence, or other dysfunctional sphincter disorders) to affect improved sphincter barrier function and/or to disrupt abnormal nerve pathways. The treatment agent can include at least one cytokine and/or at least one tissue bulking agent and/or at least one vanilloid compound to evoke a desired tissue response. The systems and methods can be used a primary treatment modality, or applied as a supplementary treatment before, during or after a primary intervention.

Abstract translation: 系统和方法将选定的治疗剂或药剂与功能异常括约肌区域（或GERD，大便失禁或其他功能失调的括约肌疾病）区域或组织接触，以影响改善的括约肌屏障功能和/或破坏 异常神经通路。 处理剂可以包括至少一种细胞因子和/或至少一种组织填充剂和/或至少一种香草酸化合物以引起所需的组织应答。 这些系统和方法可以用作主要治疗方式，或在主要干预之前，期间或之后作为补充治疗应用。